Jurata Thin Film
Developer of thermostable formulation technologies for vaccines, biologics, gene therapies and other APIs. The company formulates active materials into thin-film and liquid presentations that preserve three-dimensional structure and biological activity at ambient and elevated temperatures, enabling reduced cold-chain requirements and alternative, needle-free administration routes.
Industries
Nr. of Employees
small (1-50)
Products
Thermostable thin-film formulation platform
A platform approach that formulates biological materials into a thin, lightweight film that preserves activity at ambient and elevated temperatures and can be administered sublingually, buccally, orally or reconstituted for injection.
Thermostable thin-film formulation platform
A platform approach that formulates biological materials into a thin, lightweight film that preserves activity at ambient and elevated temperatures and can be administered sublingually, buccally, orally or reconstituted for injection.
Services
Custom formulation development and optimization
Collaborative development of thermostable film and liquid presentations tailored to a partner's API, administration route and supply-chain requirements.
Analytical development and stability testing
Biophysical product characterization, batch release testing, stability studies and potency assays to support development and regulatory submissions.
Preclinical formulation support and program management
Optimization of composition and process for thermostable presentations and execution support for preclinical studies assessing stability and delivery performance.
Custom formulation development and optimization
Collaborative development of thermostable film and liquid presentations tailored to a partner's API, administration route and supply-chain requirements.
Analytical development and stability testing
Biophysical product characterization, batch release testing, stability studies and potency assays to support development and regulatory submissions.
Preclinical formulation support and program management
Optimization of composition and process for thermostable presentations and execution support for preclinical studies assessing stability and delivery performance.
Expertise Areas
- Thermostable formulation development
- Vaccine delivery platforms
- Formulation R&D for biologics and gene therapies
- Stability testing and analytical development
Key Technologies
- Thermostable thin-film stabilization
- Liquid biologic formulation
- mRNA-LNP stabilization
- Viral-vector (adenoviral) stabilization